Hot Topics

Alison Mann
|
April 25, 2024

Transporting Bariatric Residents in the Post-Acute Setting

(opens in a new tab)
Alison Mann
|
April 25, 2024

Cannabis Use Linked to Lower Dementia Risk

(opens in a new tab)
Alison Mann
|
April 25, 2024

Otsuka and Click Therapeutics Announce the U.S. Food and Drug Administration (FDA) Clearance of Rejoyn™, the First Prescription Digital Therapeutic Authorized for the Adjunctive Treatment of Major Depressive Disorder (MDD) Symptoms

(opens in a new tab)
Alison Mann
|
April 25, 2024

The Furor Over 8 AM Meetings

(opens in a new tab)